MCQOPTIONS
Saved Bookmarks
| 1. |
Which of the following has applied to the Central Drugs Standard Control Organisation for approval of Phase-III clinical trial of Molnupiravir Capsules, to be used for the treatment of Covid-19 positive patients? |
| A. | Natco Pharma Limited |
| B. | Astra Zeneca Pharma Limited |
| C. | SAS Pharmaceuticals |
| D. | ZENERIS PHARMA PVT. LTD. |
| E. | Gracure Pharmaceuticals Limited |
| Answer» B. Astra Zeneca Pharma Limited | |